» Articles » PMID: 27659436

Carbapenem-resistant Enterobacteriaceae: Prevalence and Risk Factors in a Single Community-Based Hospital in Korea

Overview
Date 2016 Sep 24
PMID 27659436
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Carbapenemase-producing Enterobacteriaceae (CPE) are Gram-negative bacteria with increasing prevalence of infection worldwide. In Korea, 25 cases of CPE isolates were reported by the Korea Centers for Disease Control and Prevention in 2011. Most CPE cases were detected mainly at tertiary referral hospitals. We analyzed the prevalence and risk factors for carbapenem-resistant Enterobacteriaceae (CRE) in a mid-sized community-based hospital in Korea.

Materials And Methods: We retrospectively analyzed all consecutive episodes of Enterobacteriaceae in a mid-sized community-based hospital from January 2013 to February 2014. CRE was defined as organisms of Enterobacteriaceae showing decreased susceptibility to carbapenems. Risk factors for CRE were evaluated by a case-double control design. Carbapenemase was confirmed for CRE using a combined disc test.

Results: During 229,710 patient-days, 2,510 Enterobacteriaceae isolates were obtained. A total of 41 (1.6%) CRE isolates were enrolled in the study period. Thirteen species (31.7%) were Enterobacter aerogenes, 8 (19.5%) Klebsiella pneumoniae, 5 (12.2%) Enterobacter cloacae, and 15 other species of Enterobacteriaceae, respectively. Among the 41 isolates, only one (2.4%) E. aerogenes isolate belonged to CPE. For evaluation of risk factors, a total of 111 patients were enrolled and this included 37 patients in the CRE group, 37 in control group I (identical species), and 37 in control group II (different species). Based on multivariate analysis, regularly visiting the outpatient clinic was a risk factor for CRE acquisition in the control group I (P = 0.003), while vascular catheter and Charlson comorbidity index score ≥ 3 were risk factors in control group II (P = 0.010 and 0.011, each). Patients with CRE were more likely to experience a reduced level of consciousness, use a vasopressor, be under intensive care, and suffer from acute kidney injury. However, CRE was not an independent predictor of mortality compared with both control groups.

Conclusion: In conclusion, the prevalence of CRE was higher than expected in a mid-sized community-based hospital in Korea. CRE should be considered when patients have a vascular catheter, high comorbidity score, and regular visits to the outpatient clinic. This study suggests the need for appropriate prevention efforts and constant attention to CRE infection control in a mid-sized community-based hospital.

Citing Articles

Clinical Predispositions, Features, and Outcomes of Infections with Carbapenem-resistant among Critical Care Patients.

Shoala A, Nassar Y, El-Kholy A, Soliman N, Abdel-Fattah A, El-Ghawaby H Indian J Crit Care Med. 2025; 29(1):36-44.

PMID: 39802247 PMC: 11719537. DOI: 10.5005/jp-journals-10071-24876.


Antimicrobial Use and Carbapenem-Resistant Enterobacterales in Korea: A Nationwide Case-Control Study With Propensity Score Matching.

Kwon K, Kim Y, Kim S, Chang H, Hwang S, Bae S J Korean Med Sci. 2024; 39(14):e132.

PMID: 38622938 PMC: 11018987. DOI: 10.3346/jkms.2024.39.e132.


Epidemiology of Carbapenem-Resistant Bacteremia in Gyeonggi Province, Republic of Korea, between 2018 and 2021.

Lee S, Kim C, Lee H, Park K, Han S Antibiotics (Basel). 2023; 12(8).

PMID: 37627706 PMC: 10451680. DOI: 10.3390/antibiotics12081286.


Klebsiella pneumoniae carbapenamases in Escherichia coli isolated from humans and livestock in rural south-western Uganda.

Tuhamize B, Asiimwe B, Kasaza K, Sabiiti W, Holden M, Bazira J PLoS One. 2023; 18(7):e0288243.

PMID: 37440483 PMC: 10343067. DOI: 10.1371/journal.pone.0288243.


Prevalence of carbapenemase-producing Enterobacteriaceae from human clinical samples in Ethiopia: a systematic review and meta-analysis.

Alemayehu E, Fiseha T, Gedefie A, Tesfaye N, Ebrahim H, Ebrahim E BMC Infect Dis. 2023; 23(1):277.

PMID: 37138285 PMC: 10155349. DOI: 10.1186/s12879-023-08237-5.


References
1.
Ling M, Tee Y, Tan S, Amin I, How K, Tan K . Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore. Antimicrob Resist Infect Control. 2015; 4:26. PMC: 4477303. DOI: 10.1186/s13756-015-0066-3. View

2.
ANDERSON K, Lonsway D, Rasheed J, Biddle J, Jensen B, McDougal L . Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol. 2007; 45(8):2723-5. PMC: 1951220. DOI: 10.1128/JCM.00015-07. View

3.
Logan L, Renschler J, Gandra S, Weinstein R, Laxminarayan R . Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012. Emerg Infect Dis. 2015; 21(11):2014-21. PMC: 4622248. DOI: 10.3201/eid2111.150548. View

4.
Sader H, Castanheira M, Flamm R, Mendes R, Farrell D, Jones R . Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013). Diagn Microbiol Infect Dis. 2015; 83(2):183-6. DOI: 10.1016/j.diagmicrobio.2015.06.011. View

5.
Schwaber M, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y . Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2007; 52(3):1028-33. PMC: 2258527. DOI: 10.1128/AAC.01020-07. View